Insiders Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
3.36 ^USD	+1.20%		+2.13%	+34.40%

May. 20	Whitefort Capital Management Sends an Open Letter to Shareholders of Arbutus Biopharma	CI
May. 17	Sector Update: Health Care Stocks Mixed Late Afternoon	MT

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Arbutus Biopharma Corporation Announces Retirement of Chief Scientific Officer, Michael J. Sofia Effective December 31, 2024	May. 02	CI
Arbutus Biopharma Posts Q3 Net Loss, Lower Revenue; CEO to Retire, 24% Research Staff Cut	Nov. 07	MT
Arbutus Biopharma Corporation Announces CEO Changes	Nov. 07	CI
Arbutus Biopharma Corporation Announces President Changes	Nov. 07	CI
Arbutus Biopharma Corporation Announces the Appointment of Melissa V. Rewolinski to Its Board of Directors	23-07-12	CI
Arbutus Biopharma Promotes Dr. Karen Sims to Chief Medical Officer, Hires Christopher Naftzger as Chief Compliance Officer	23-07-10	MT
Arbutus Biopharma Corporation Appoints Two New Executives	23-07-10	CI
Arbutus Biopharma Corporation Announces Resignation of Tram Tran from the Board of Directors, Effective on February 26, 2023	23-01-27	CI
Eupraxia Pharmaceuticals Inc. Appoints Industry Veteran, Paul Brennan, As Chief Business Officer	22-11-01	MT
Arbutus Biopharma Corporation Appoints Mike Mcelhaugh as Chief Operating Officer, Effective as of November 1, 2022	22-10-24	CI
Arbutus Biopharma Corporation Announces Resignation of Gaston Picchio as Chief Development Officer	22-09-30	CI
Insider Sell: Arbutus Biopharma	21-12-06	MT
Arbutus Biopharma Corporation Appoints Tram Tran, M.D. to its Board of Directors	21-11-11	CI
Arbutus Biopharma Corporation Appoints Lisa M. Caperelli as Vice President, Investor Relations	21-09-21	CI
Eupraxia Pharmaceuticals : Names New CFO	21-05-03	MT
Arbutus Biopharma Corporation Appoints Eric Venker as Director	20-02-19	CI
Arbutus Biopharma Corporation Names Andrew Cheng to its Board of Directors	19-08-20	CI
Arbutus Biopharma Corporation Announces Management Changes	19-06-17	CI
Arbutus Biopharma Corporation Announces Executive Changes, Effective March 31, 2019	19-03-15	CI
Arbutus Biopharma Corporation Announces Board Changes	18-11-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Arbutus Biopharma Corporation

Equities

ABUS

CA03879J1003

Insiders

Filters